Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies

Clinical trial NCT07526714 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07526714
Sponsor: Central Hospital, Nancy, France
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Primary Immune Deficiencies Benign Lymphoproliferative Disorder

Start date: 2026-04-01
Primary completion: 2028-03-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.